NCT05250557Recruiting
Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease
Prognostic Impact of Lesion-specific Hemodynamic Index and Disease Characteristics in Patients With Coronary Artery Disease Assessed by Fractional Flow Reserve
Source: ClinicalTrials.gov · Last updated 22 Feb 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR according to treatment strategy, and to find the prognostic implications of post-PCI FFR after adjustment of various clinical and disease characteristics, and to construct a comprehensive risk prediction model for post-PCI outcomes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2429 (estimated)
- First submitted
- 10 Feb 2022
- Start date
- 1 Aug 2021
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT05250557
What you commit to
- Study type: Observational
- Planned participants: 2429
- From 1 Aug 2021 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery history
Other illness
- Chronic renal failure (estimated glomerular filtration rate \<30)
- Primary myocardial or valvular disease
- Hemodynamically unstable clinical conditions
Lab values
- Left ventricular ejection fraction \< 30%
Age
- Life expectancy \< 2 years
Who the study is looking for
- Age ≥20 years
- All comers who underwent successful FFR measurement and pullback tracing
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.